WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008101064) METHOD OF TREATING ARTHRITIS, PAIN OR INFLAMMATION WITH NAPROXEN 2(METHANESULFONYL)ETHYL ESTER AND AN H2 RECEPTOR ANTAGONIST
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/101064    International Application No.:    PCT/US2008/053938
Publication Date: 21.08.2008 International Filing Date: 14.02.2008
IPC:
A01N 43/78 (2006.01), A61K 31/425 (2006.01)
Applicants: LOGICAL THERAPEUTICS, INC. [US/US]; 300 Second Avenue, Waltham, Massachusetts 02451 (US) (For All Designated States Except US).
FINK, Mitchell, P. [US/US]; (US) (For US Only).
SEWELL, Kathryn, Lea [US/US]; (US) (For US Only)
Inventors: FINK, Mitchell, P.; (US).
SEWELL, Kathryn, Lea; (US)
Agent: MILLER, Raymond, A.; Pepper Hamilton LLP, 500 Grant Street, One Mellon Bank Center, 50th floor, Pittsburgh, PA 15219 (US)
Priority Data:
60/889,777 14.02.2007 US
Title (EN) METHOD OF TREATING ARTHRITIS, PAIN OR INFLAMMATION WITH NAPROXEN 2(METHANESULFONYL)ETHYL ESTER AND AN H2 RECEPTOR ANTAGONIST
(FR) PROCÉDÉ POUR TRAITER L'ARTHRITE, LA DOULEUR OU UNE INFLAMMATION AVEC UN ESTER DE NAPROXÈNE 2(MÉTHANESULFONYL)ÉTHYLE, ET UN ANTAGONISTE DE RÉCEPTEUR DE H2
Abstract: front page image
(EN)Embodiments of the present invention provide methods of treating pain, arthritis and inflammation comprising administering naproxen 2(methanesulfonyl)ethyl ester and an H2 receptor antagonist. Further embodiments provide pharmaceutical compositions comprising naproxen 2(methanesulfonyl)ethyl ester and an H2 receptor antagonist.
(FR)L'invention concerne des procédés pour traiter la douleur, l'arthrite et une inflammation, comprenant l'administration d'ester de naproxène 2(méthanesulfonyl)éthyle, et d'un antagoniste de récepteur de H2. Des modes de réalisation supplémentaires fournissent des compositions pharmaceutiques comprenant de l'ester de naproxène 2(méthanesulfonyl)éthyle, et un antagoniste de récepteur de H2.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)